Dai-ichi Life Insurance Company, Ltd
InsurancePosition in NBIX — Neurocrine Biosciences Inc
CIK 1697728
TOKYO, M0
Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,484,448
+$774,727 QoQ
Shares Held
14,741
+13.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#288
of 768 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Dai-ichi Life Insurance Company, Ltd holds $9,556,921 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (26.0% of the industry book) .
All Filings in NBIX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,484,448 | 14,741 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,709,721 | 12,978 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,840,669 | 12,978 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,821,851 | 12,978 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,364,867 | 10,859 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,502,747 | 40,712 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,687,136 | 41,664 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,852,951 | 42,119 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,673,828 | 48,477 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $2,889,148 | 20,948 | Shares | Defined | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||